Empatica Gets FDA Clearance for Parkinson's Monitoring Platform

Aug 19, 2026
Empatica received FDA 510(k) clearance for its Health Monitoring Platform for Parkinson's, which uses wearables, an app, cloud technology, and a clinician portal to track symptoms over time.

Empatica announced in a press release that its Empatica Health Monitoring Platform for Parkinson's has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The clearance expands Empatica's monitoring platform into Parkinson's after its 2025 acquisition of PKG Health.

The platform uses wearable devices, a patient app, secure cloud technology, and a clinician portal to monitor symptoms over time. It provides measures for bradykinesia, dyskinesia, tremor, sleep, medication compliance, and other aspects of Parkinson's management.

The algorithms have been studied in more than 70 publications reviewed by peers and used across more than 150 hospitals and clinical sites worldwide. Empatica said the clearance is its twelfth FDA clearance.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.